摘要 |
The invention provides methods of diagnosing multiple sclerosis (MS) patients, including methods of identifying multiple sclerosis patients who are at increased risk of developing a secondary autoimmune disease following lymphocyte depletion, caused, e.g., by treatment with an anti-CD52 antibody. Also embraced are methods of selecting treatment regimens for MS patients, and reagents useful in the above methods. |
申请人 |
CAMBRIDGE ENTERPRISE;COLES, ALASDAIR, J.;JONES, JOANNE, L.;COMPSTON, ALASTAIR |
发明人 |
COLES, ALASDAIR, J.;JONES, JOANNE, L.;COMPSTON, ALASTAIR |